최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.28 no.11 = no.223, 2018년, pp.1316 - 1320
The effects of a green tea extract (GTE) were examined using the MCF-7 human breast cancer cell line. Cell viability assays using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays revealed that GTE had a significant cytotoxic effect on MCF-7 cells, depending on the concentrat...
Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G. and Corti, A. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high grade prostate intraepithelial neoplasia. Cancer Res. 66, 1234-1240.
Butt, M. S. and Sultan, M. T. 2009. Green tea: nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 49, 463-473.
Caffo, O., Doglioni, C., Veronese, S., Bonzanini, M., Marchetti, A., Buttitta, F., Fina, P., Leek, R., Morelli, L., Palma, P. D., Harris, A. L. and Barbareschi, M. 1996. Prognostic value of p21WAF1 and p53 expression in breast carcinoma: An immuno-histochemical study in 261 patients with long term follow-up. Clin. Cancer Res. 2, 1591-1599.
Chen, Q. M., Bartholomew, J. C., Campisi, J., Acosta, M., Reagan, J. D. and Ames, B. N. 1998. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem. J. 332, 43-50.
Clement, Y. 2009. Can green tea do that? A literature review of the clinical evidence. Prev. Med. 49, 83-87.
Fung, T. K. and Poon, R. Y. 2005. A roller coaster ride with the mitotic cyclins. Semin. Cell Dev. Biol. 16, 335-342.
Henning, S. M., Wang, P., Carpenter, C. L. and Heber, D. 2013. Epigenetic effects of green tea polyphenols in cancer. Epigenomics 5, 729-741.
Iwasaki, M., Inoue, M., Sasazuki, S., Sawada, N., Yamaji, T., Shimazu, T., Willett, W. C. and Tsugane, S. 2010. Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res. 12, R88.
Kim, Z., Min, S. Y., Yoon, C. S., Jung, K. W., Ko, B. S., Kang, E., Nam, S. J., Lee, S. and Hur, M. H. 2015. The basic facts of Korean breast cancer in 2012: Results from a nationwide survey and breast cancer registry database. J. Breast Cancer 18, 103-111.
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.
Khan, N., Afaq, F., Saleem, M., Ahmad, N. and Mukhtar, H. 2006. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66, 2500-2505.
May, P. and May, E. 1999. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18, 7621-7636.
Morgan, D. O. 1995. Principles of CDK regulation. Nature 374, 131-134.
Ogunleye, A. A., Xue, F. and Michels, K. B. 2010. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 119, 477-484.
Rey, M., Fernandez, P. L., Jares, P., Rey, M. J., Fernandez, P. L., Jares, P., Munoz, M., Nadal, A., Peiro, N., Nayach, I., Mallofre, C., Muntane, J., Campo, E., Estape, J. and Cardesa, A. 1998. P21WAF1/CIP1 is associated with cyclin D1 CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J. Pathol. 184, 265-271.
Salnikow, K., Costa, M., Figg, W. D. and Blagosklonny, M. V. 2000. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res. 60, 5630-5634.
Schwartz, D. and Rotter, V. 1998. P53-dependent cell cycle control: response to genotoxic stress. Semin. Cancer Biol. 8, 325-336.
Shirakami, Y., Shimizu, M. and Moriwaki, H. 2012. Cancer chemoprevention with green tea catechins: from bench to bed. Curr. Drug Targets. 13, 1842-1857.
Wakasugi, E., Kobayashi, T., Tanaki, Y., Ito, Y., Miyashiro, I., Komoike, Y., Takeda, T., Shin, E., Takatsuka, Y., Kikkawa, N., Monden, T. and Monden, M. 1997. p21 and p53 protein expression in breast cancer. Am. J. Clin. Pathol. 107, 684-691.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.